NasdaqCM - Nasdaq Real Time Price USD

Intelligent Bio Solutions Inc. (INBS)

1.2600
+0.0300
+(2.44%)
As of 12:29:33 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
2,936.4720
3,111.7810
1,256.8720
0
0
Cost of Revenue
1,209.6320
1,686.1550
930.2040
0
--
Gross Profit
1,726.8400
1,425.6260
326.6680
0
--
Operating Expense
12,081.5480
11,708.8000
8,763.2310
8,336.8760
5,573.4820
Operating Income
-10,354.7080
-10,283.1740
-8,436.5630
-8,336.8760
-5,573.4820
Net Non Operating Interest Income Expense
57.6190
-82.3180
-213.8580
6.8870
-1,079.8020
Other Income Expense
-0.5410
174.5600
-2,014.1340
-3.9870
-406.9170
Pretax Income
-10,297.6300
-10,190.9320
-10,664.5550
-8,333.9760
-7,060.2010
Tax Provision
--
--
--
--
0
Net Income Common Stockholders
-10,262.8760
-10,156.7590
-10,631.7200
-8,306.0510
-7,037.2860
Diluted NI Available to Com Stockholders
-10,262.8760
-10,156.7590
-10,631.7200
-8,306.0510
-7,037.2860
Basic EPS
-1.33
-6.38
-127.00
-136.80
-149.93
Diluted EPS
-1.33
-6.38
-127.00
-136.80
-149.93
Basic Average Shares
4,284.0500
1,592.7460
83.7170
61.1050
56.5920
Diluted Average Shares
4,284.0500
1,592.7460
83.7170
61.1050
56.5920
Total Operating Income as Reported
-10,354.7080
-10,283.1740
-12,595.2330
-8,336.8760
-5,573.4820
Rent Expense Supplemental
39.6090
--
--
--
--
Total Expenses
13,291.1800
13,394.9550
9,693.4350
8,336.8760
5,573.4820
Net Income from Continuing & Discontinued Operation
-10,262.8760
-10,156.7590
-10,631.7200
-8,306.0510
-7,037.2860
Normalized Income
-10,262.3350
-10,331.3190
-8,617.5860
-8,302.0640
-6,766.0610
Interest Income
162.9980
84.8220
9.6760
14.4260
13.8060
Interest Expense
105.3790
167.1400
223.5340
7.5390
1,093.6080
Net Interest Income
57.6190
-82.3180
-213.8580
6.8870
-1,079.8020
EBIT
-10,192.2510
-10,023.7920
-10,441.0210
-8,326.4370
-5,966.5930
EBITDA
-8,996.9880
-8,810.7070
-9,474.2890
-8,326.4370
-5,966.5930
Reconciled Cost of Revenue
1,206.4240
1,674.3440
930.2040
0
--
Reconciled Depreciation
1,195.2630
1,213.0850
966.7320
0
--
Net Income from Continuing Operation Net Minority Interest
-10,262.8760
-10,156.7590
-10,631.7200
-8,306.0510
-7,037.2860
Total Unusual Items Excluding Goodwill
-0.5410
174.5600
-2,014.1340
-3.9870
-271.2250
Total Unusual Items
-0.5410
174.5600
-2,014.1340
-3.9870
-271.2250
Normalized EBITDA
-8,996.4470
-8,985.2670
-7,460.1550
-8,322.4500
-5,695.3680
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
6/30/2021 - 12/23/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AMIX Autonomix Medical, Inc.
1.8100
-3.23%
 
TNON Tenon Medical, Inc.
1.1250
+0.45%
 
TIVC Tivic Health Systems, Inc.
4.4900
+4.66%
 
AIMD Ainos, Inc.
0.5215
-1.23%
 
HSCS HeartSciences Inc.
3.8700
+2.11%
 
APYX Apyx Medical Corporation
1.4700
-1.34%
 
BBLG Bone Biologics Corporation
0.8273
+8.95%
 
NAOV NanoVibronix, Inc.
1.2350
-5.00%
 
MOVE Movano Inc.
0.7897
-12.06%
 
VERO Venus Concept Inc.
2.3175
+5.34%